Carson Wealth (CWM LLC)’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-117
Closed -$1K 4634
2023
Q3
$1K Buy
117
+52
+80% +$432 ﹤0.01% 4133
2023
Q2
$1K Hold
65
﹤0.01% 4130
2023
Q1
$0 Hold
65
﹤0.01% 4427
2022
Q4
$0 Buy
65
+37
+132% +$275 ﹤0.01% 4333
2022
Q3
$0 Hold
28
﹤0.01% 4265
2022
Q2
$0 Buy
+28
New +$214 ﹤0.01% 4173

Other funds holding PNT

Carson Wealth (CWM LLC)'s PNT Position: Q4 2023 in Review

Carson Wealth (CWM LLC) sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 117 shares — an estimated $1K sold.

Carson Wealth (CWM LLC) first reported a position in PNT in Q2 2022 and held it in 6 quarters. The position peaked at $1K in Q3 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Carson Wealth (CWM LLC) reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 117 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $1K.
  • Carson Wealth (CWM LLC) first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2022 and held it in 6 quarters.
  • Carson Wealth (CWM LLC)'s POINT Biopharma Global Inc. Common Stock position peaked at $1K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q4 2023, filed 1 Feb 2024.